Anti-hyperlipidemic effect of triglize, a polyherbal formulation

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 3, 2010, Pages 118-122

  Parasuraman, S ^a   Kumar, E P ^a   Kumar, Anil ^a   Emerson, S F ^b  

^a JSS COLLEGE OF PHARMACY   (India)

^b Herbal Division of Apex Laboratories   (India)

Author keywords

Anti hyperlipidemia; High fat diet; Polyherbal formulation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLIUM SATIRUM EXTRACT; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BOERHAAVIA DIFFUSA EXTRACT; CISSUS QUADRANGULARIS EXTRACT; COMMIPHORA MUKUL EXTRACT; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYLLANTHUS EMBILICA EXTRACT; PLANT EXTRACT; TERMINALIA ARJUNA EXTRACT; TERMINALIA BELLETICA EXTRACT; TERMINALIA CHEBULA EXTRACT; TRIACYLGLYCEROL; TRIBULUS TERRESTRIS EXTRACT; TRIGLIZE; TRIGONELLA FOENUMGRAECUM EXTRACT; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; BODY WEIGHT; BOERHAAVIA; CHOLESTEROL BLOOD LEVEL; CISSUS QUADRANGULARIS; COMMIPHORA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FENUGREEK; GARLIC; HISTOPATHOLOGY; HYPERLIPIDEMIA; ISOLATED LIVER; LIPID ANALYSIS; LIPID DIET; LIVER PROTECTION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PHYLLANTHUS; RAT; TERMINALIA; TREATMENT OUTCOME; TRIBULUS TERRESTRIS;

EID: 77954752920     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Carnethon MR, Lynch EB, Dyer AR, Lloyd-Jones DM, Renwei W, Garside DB, Greenland P. Comparison of risk factors for cardiovascular mortality in black and white adults. Arch Intern Med 2006; 166:1196-1202.
2. th ed. Churchill livingstone, Edinburgh.
3. Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin- related adverse events: a meta-analysis. Clin Ther 2006; 28:26-35.
4. Singh BB, Vinjamury SP, Der-Martirosian C, Kubik E, Mishra LC, Shepard NP, et al. Ayurvedic and collateral herbal treatments for hyperlipidemia: a systematic review of randomized controlled trials and quasi- experimental designs. Alternative Therapies 2007; 13:22-8.
5. Freidwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem1972; 18:499-502.
6. Friedlander Y, Kark JD, Eisenberg S, Stein Y. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: a comparison of methods in the Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci. 1982; 18:1242-52.
7. Noriko S, Mitsuhide N, Takeshi U, Tetsuya T, Takayoshi S, Kazunori Y, et al. Leptin-to-Adiponectin Ratio as a Potential Atherogenic Index in Obese Type 2 Diabetic Patients. Diabetes care 2004; 27:2488-90
8. Mukherjee, KL. Medical Laboratory Technology, vol- I. Tata MC-Graw Hill Publication Company, New Delhi; 1988.
9. Martin M, Annie B. The positive relationship between alcohol and heart disease in eastern Europe: potential physiological mechanisms. J R Soc Med 1998; 9:402-7.
10. Takaaki S, Vaijinth SK, Moti LK. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol. Arterioscler Thromb Vasc Biol 2001; 21:1783-9.
11. Kottai MA, Suthupathy S, Manavalan R, Karar PK. Hypolipidemic effect of metyhenolic extract of Dolichos biflorus Linn. in high fat diet fed rats. Indian J Exp Biol 2005; 43:522-5.
12. Fawzia MR, Amr YE, Soad MA, Aida MI, Mona A. The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats. Lipids Health Dis 2005; 4: 22.
13. Jagetia GC, Baliga MS. The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study. J Med Food 2004; 7:343-8.
14. Wang X, Greilberger J, Ledinski G, Kager G, Paigen B, Jurgens G. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Atherosclerosis 2004; 172:239-46.
15. Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, et al. The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand. Mol Pharmacol 2005; 67:948-54.
16. Anila L, Vijayalakshmi N R. Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J Ethnopharmacol 2002; 79:81-7.
17. Pawar RS, Bhutani KK. Effect of oleanane triterpenoids from Terminali arjuna- a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine 2005; 12:391-3.
18. Ram A. Effect of Plumbago zeglanica in hyperlipidemic rabbit and its modification by vitamin E. Indian J